MYC and medulloblastoma: We performed comprehensive metabolic studies—employing liquid chromatography/mass spectrometry (LC/MS) and uniformly labeled glucose and glutamine—of human MYC-amplified medulloblastoma by comparing the metabolic profiles of tumor cells in three different environments—in vitro, in flank xenografts and in orthotopic xenografts.